CAPITAL COMMITMENT (Details Narrative) |
1 Months Ended | 2 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|---|
|
Feb. 27, 2023
USD ($)
shares
|
Sep. 13, 2022
USD ($)
shares
|
Jan. 31, 2024
USD ($)
shares
|
Jan. 31, 2024
CNY (¥)
shares
|
Nov. 30, 2024
USD ($)
|
Sep. 30, 2024
USD ($)
|
Sep. 30, 2023
USD ($)
|
Sep. 30, 2022
USD ($)
|
|
| Number of shares issued, value | ||||||||
| Maius Pharmaceutical Co. Ltd [Member] | ||||||||
| Number of shares issued, value | $ 30,776 | $ 46,112 | ||||||
| ELITE RAINBOW LIMITED [Member] | Maius Pharmaceutical Co. Ltd [Member] | ||||||||
| Number of shares issued | shares | 824 | 824 | 824 | |||||
| Number of shares issued, value | $ 30,741 | $ 1,990,191 | ¥ 13,846,154 | |||||
| Consultant fees | 30,741 | |||||||
| ELITE RAINBOW LIMITED [Member] | Listing Advisory Agreement [Member] | Maius Pharmaceutical Co. Ltd [Member] | ||||||||
| Number of shares issued | shares | 824 | |||||||
| Number of shares issued, value | $ 30,741 | |||||||
| Net assets | $ 435,500 | |||||||
| Consultant fees | $ 3,000,000 | $ 3,000,000 | ||||||